Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSC Secretome vs Minoxidil in Androgenetic Alopecia
NCT06066827Unknown
- Start
- Aug 2023
- Primary completion
- Nov 2023
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Randomised, single-blind trial of AT-MSC secretome in androgenetic alopecia (AGA) (3 arms). Primary endpoints: Improvement of alopecia in physical examination at Week 12, Macroscopic hair growth documented at Week 12 and 2 more. Status: unknown.
02
Drugs
AT-MSC secretome
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06066827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06066827.